HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Twenty one years of hemodialysis in a patient with primary hyperoxaluria].

Abstract
We report a male patient with primary hyperoxaluria from childhood who survived more than 21 years on conventional haemodialysis. Despite the severity of his bone disease, he was married and actively employed up until 2 years before his death. His condition really worsened a few months before his death. He presented with only renal and bone involvement and had hardly any cardiovascular complications, that was probably a reason for his prolonged survival. Such an evolution is very unusual and we speculate that the length of haemodialysis sessions in addition to the large surface of the membrane probably contributed to such an outcome. During the time period on HD, anemia was transiently controlled by recombinant erythropoietin despite oxalate involvement of the marrow. He was refused a liver-kidney transplant and died from malnourishment at 43 years of age. To our knowledge, such an outcome has not yet been reported. It shows that careful prolonged hemodialysis sessions should be helped in admet patients without severe cardiovascular involvement.
AuthorsT Hachache, H Meftahi, M Forêt, R Milongo, F Kuentz, P Gaudin, J Maurizi, J Vallin, D J Cordonnier
JournalNephrologie (Nephrologie) Vol. 17 Issue 4 Pg. 243-6 ( 1996) ISSN: 0250-4960 [Print] Switzerland
Vernacular TitleVingt et un ans d'hémodialyse chez un patient atteint d'hyperoxalurie primitive.
PMID8768456 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Recombinant Proteins
  • Erythropoietin
Topics
  • Adult
  • Erythropoietin (therapeutic use)
  • Humans
  • Hyperoxaluria, Primary (complications, therapy)
  • Kidney Failure, Chronic (etiology, therapy)
  • Male
  • Recombinant Proteins (therapeutic use)
  • Renal Dialysis
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: